Johnson & Johnson
JNJ
Company Profile
Business description
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Contact
One Johnson and Johnson Plaza
New Brunswick NJ 08933
USAT: +1 732 524-0400
E: investor-relations@its.jnj.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
134,400
Johnson & Johnson News & Analysis
stocks
3 undervalued US value shares with moats
Value continues to underperform but it may be a function of how we think about the investing style.
stocks
Warren Buffet's latest buys and sells
Undervalued stocks in Berkshire Hathaway’s portfolio, as well as its latest buys and sells from its third-quarter 2023 13F filing.
personal-finance
You've heard of greenwashing, now meet 'social washing'
'The question is no longer "do you want to buy Wheat Thins?" for example, the question is now "will you support Wheat Thins in the fight against lyme disease?"'
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,206.10 | 72.70 | 0.89% |
| CAC 40 | 7,724.32 | 97.19 | 1.27% |
| DAX 40 | 18,748.18 | 213.62 | 1.15% |
| Dow JONES (US) | 40,000.90 | 247.15 | 0.62% |
| FTSE 100 | 8,252.91 | 29.57 | 0.36% |
| HKSE | 18,293.38 | 461.05 | 2.59% |
| NASDAQ | 18,398.45 | 115.04 | 0.63% |
| Nikkei 225 | 41,190.68 | 1,033.34 | -2.45% |
| NZX 50 Index | 12,134.97 | 76.68 | 0.64% |
| S&P 500 | 5,615.35 | 30.81 | 0.55% |
| S&P/ASX 200 | 7,959.30 | 69.70 | 0.88% |
| SSE Composite Index | 2,971.29 | 0.91 | 0.03% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Core Lithium Ltd CXO | 0.11 | 0.01 | 10.00% |
| Red 5 Ltd RED | 0.43 | 0.01 | 1.19% |
| Imugene Ltd IMU | 0.06 | 0.01 | 9.26% |
| Telstra Group Ltd TLS | 3.82 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 2.34 | 0.16 | 7.34% |
| Mirvac Group MGR | 2.01 | 0.08 | 4.15% |
| Latin Resources Ltd LRS | 0.17 | 0.00 | 0.00% |
| Melbana Energy Ltd MAY | 0.02 | 0.00 | -4.35% |
| Botanix Pharmaceuticals Ltd BOT | 0.38 | 0.06 | 16.92% |